85 patients with T2DM were randomized to receive combination of SOD, alpha lipoic acid, acetyl l-carnitine, and vitamin B12 (B12) in a prospective, double-blind, placebo-controlled research. This evidence concerns the gene SOD1 and type 2 diabetes mellitus.